Unlock instant, AI-driven research and patent intelligence for your innovation.

Anti-tumor pharmaceutical composition, and preparation method and application thereof

A composition and anti-tumor technology, applied in the field of anti-tumor drugs, can solve the problems of methotrexate and pimozide tumors that have not yet been seen, and achieve synergistic anti-tumor tumor metastasis, prevent tumor metastasis, and good safety Effect

Active Publication Date: 2021-08-27
WEST CHINA HOSPITAL SICHUAN UNIV
View PDF11 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0007] At present, there is no report on the combined use of methotrexate and pimozide in the treatment of tumors

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Anti-tumor pharmaceutical composition, and preparation method and application thereof
  • Anti-tumor pharmaceutical composition, and preparation method and application thereof
  • Anti-tumor pharmaceutical composition, and preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0026] Example 1, Pimozide and MTX combined to inhibit MKN45 cells

[0027] 1. Method

[0028] MKN45 cell line (human gastric cancer cell line) was cultured in vitro, the medium was RPMI 1640 complete medium (RPMI1640 basal medium + 10% newborn bovine serum), and the cells were placed at 37°C, 5% CO 2 cultured in a cell culture incubator. After the cell confluency reached 80%, the adherent cells were digested with 0.25% trypsin. After the cells were digested, RPMI 1640 complete medium was added to stop the digestion. After centrifugation at 300g×5min, the cells were collected. Resuspend the cell pellet in complete medium to make a single cell suspension, and perform cell counting. Cells were diluted with complete medium and seeded in a 96-well plate at a density of 12,000 cells per well, with a volume of 100 μL per well. Set blank control wells: only contain 100 μL complete medium; cell control wells: only contain cells and complete medium, without drug treatment; drug tr...

Embodiment 2

[0041] Example 2, Pimozide combined with MTX inhibits MKN74 cells

[0042] 1. Method

[0043] Taking the MKN74 cell line (human gastric cancer highly metastatic cell line) as the test object, it was treated by the method in Example 1 (the cells were cultured in a 96-well plate at a density of 8000 / well, and the medium was also RPMI 1640 complete culture medium).

[0044] 2. Results

[0045]The results of using Pimozide (pimozide) or MTX (methotrexate) alone are shown in Table 3. When Pimozide is used alone, the dose of Pimozide is too small (1μM) has almost no inhibitory effect on MKN74 cells, only large doses of Pimozide (2 ~ 4μM) can inhibit MKN74 cells (survival rate <70%), with the increase of Pimozide concentration , the inhibitory effect increases. When MTX was used alone, the inhibitory effect on MKN74 cells was poor.

[0046] The results of the combined use of Pimozide (pimozide) and MTX (methotrexate) are shown in Table 3. It can be seen from Table 3 that the co...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides an anti-tumor pharmaceutical composition, and a preparation method and application thereof, and belongs to the field of anti-tumor drugs. The pharmaceutical composition is prepared from methotrexate and pimozide. The methotrexate and the pimozide are combined for use, so that the inhibition effect on tumor cells, especially gastric cancer cells and highly metastatic gastric cancer cells, is remarkably superior to that of the methotrexate and the pimozide which are independently used, the effect is remarkable, and the synergistic anti-tumor and anti-tumor metastasis effects are achieved. In addition, the methotrexate and the pimozide are combined for use, so that the dosage of the medicine can be reduced, the toxic and side effects of the medicine are reduced, and the safety is better. The methotrexate and the pimozide are used as active ingredients to prepare the anti-tumor medicine, or the methotrexate and the pimozide are used for preparing the anti-tumor combined medicine, and the anti-tumor combined medicine has a good application prospect.

Description

technical field [0001] The invention belongs to the field of antitumor drugs, and in particular relates to an antitumor pharmaceutical composition and its preparation method and application. Background technique [0002] Tumor refers to the neogrowth formed by the proliferation of local tissue cells in the body under the action of various tumorigenic factors, because this neogrowth is mostly in the form of space-occupying blocky protrusions, also known as neoplasm (neoplasm) . Tumors are divided into benign tumors and malignant tumors. Tumors, especially malignant tumors, seriously threaten human health. At present, tumor treatment methods include traditional surgery, radiotherapy and chemotherapy, small molecule inhibitors, monoclonal antibody therapy, and cell-targeted therapy. Traditional surgical treatment cannot guarantee the complete resection of the lesion, and it is easy to relapse; radiotherapy and chemotherapy can affect normal cells, resulting in strong toxic a...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/519A61K31/454A61P35/00A61P35/04A61P1/00
CPCA61K31/519A61K31/454A61P35/00A61P35/04A61P1/00A61K2300/00
Inventor 牟大超吴沙沙冉晶晶缪治永周轶
Owner WEST CHINA HOSPITAL SICHUAN UNIV